OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial
Cristiano de Pádua Souza, Ana Carneiro, Ana Cecília de Oliveira Lessa, et al.
Breast Cancer Research and Treatment (2023) Vol. 202, Iss. 1, pp. 57-65
Open Access | Times Cited: 5

Showing 5 citing articles:

Neoadjuvant Strategies for Triple Negative Breast Cancer: Current Evidence and Future Perspectives
Zhenjun Huang, Qing Peng, Luhui Mao, et al.
MedComm – Future Medicine (2025) Vol. 4, Iss. 1
Open Access

Role of imaging based response assesment for adapting neoadjuvant systemic therapy for breast cancer: A systematic review
Oğuz Lafcı, Daphne Resch, Ambra Santonocito, et al.
European Journal of Radiology (2025), pp. 112105-112105
Closed Access

Effectiveness and safety of neoadjuvant therapy in triple-negative breast cancer in a real-world population
Cristina Galindo García, Rocío Díaz Acedo, Silvia Artacho Criado, et al.
Farmacia Hospitalaria (2024) Vol. 48, Iss. 6, pp. 278-285
Open Access

[Artículo traducido] Efectividad y seguridad del tratamiento neoadyuvante del cáncer de mama triple negativo en la vida real
Cristina Galindo García, Rocío Díaz Acedo, Silvia Artacho Criado, et al.
Farmacia Hospitalaria (2024) Vol. 48, Iss. 6, pp. T278-T285
Open Access

Circulating microRNAs as potential biomarkers in triple-negative breast cancer: a translational research study of the NACATRINE trial
Ana Julia Aguiar de Freitas, C.R. Nunes, Max S. Mano, et al.
Future Oncology (2023) Vol. 20, Iss. 1, pp. 25-38
Closed Access

Page 1

Scroll to top